Vote au Parlement européen
Végétaux obtenus au moyen de certaines nouvelles techniques génomiques et les denrées alimentaires et aliments pour animaux qui en sont dérivés, et modification du règlement (UE) 2017/625
Résultat global
Rejeté- 201 Pour
- 431 Contre
- 29 Abstention
- 58 N'a pas voté
Comment nous comptons
- Les votes Pour, Contre et Abstention proviennent du procès-verbal de vote nominal du Parlement européen.
- « N'a pas voté » est déduit : députés avec un mandat le jour du vote pour lesquels aucun vote n'est enregistré. Les abstentions ne comptent pas pour cela.
- Les corrections de vote ultérieures sont affichées mais ne modifient pas le résultat officiel.
- Chaque vote (vote global, amendement, vote partiel) compte séparément. C'est pourquoi les totaux peuvent différer des pages qui comptent différemment.
Statut et procédure
Résultat tel qu'enregistré par le Parlement européen.
- Vote du
- Dernière étape documentée
- Journal officiel · (il y a 140 jours)
- Prochaine étape prévue
- Aucune autre étape n'est prévue dans la source.
- Publication au Journal officiel documentée
Déroulement de la procédure
2023/0226(COD) · COD
Activités documentées de la procédure. Elles ne prouvent pas qu’une loi est entrée en vigueur.
- Documenté: Renvoi
- Documenté: Examen en commission
- Documenté: Plénière
- Documenté: Négociations
- Documenté: Plénière
- Documenté: Négociations
- Documenté: Examen en commission
- Documenté: Renvoi
- Documenté: Examen en commission
- Documenté: Plénière
- Documenté: Signature
- Documenté: Autres activités
- Dernier documenté: Journal officiel
Activités documentées (32)
- Renvoi en commission
- Dépôt du rapport en commission
- Dépôt d’amendements en commission
- Dépôt d’amendements en commission
- Dépôt d’amendements en commission
- Dépôt d’amendements en commission
- Adoption de l’avis en commission
- Adoption du rapport en commission
- Dépôt en séance plénière
- Débat en séance plénière
- Texte amendé en séance plénière
- Renvoi en commission pour négociations interinstitutionnelles
- Vote en séance plénière
- Résultats du vote en séance plénière
- Position du Parlement en première lecture
- Vote en séance plénière
- Résultats du vote en séance plénière
- Négociations interinstitutionnelles
- Négociations interinstitutionnelles
- Négociations interinstitutionnelles
- Négociations interinstitutionnelles
- Accord provisoire approuvé en commission
- Renvoi en commission
- Dépôt d’amendements en commission
- Dépôt du rapport en commission
- Adoption du rapport en commission
- Dépôt en séance plénière
- Autre activité documentée
- Signature
- Vote en séance plénière
- Résultats du vote en séance plénière
- Publication au Journal officiel
Activités prévues (réalisation non confirmée)
- Débat en séance plénière
- Vote en séance plénière
- Vote en séance plénière
- Vote en séance plénière
Fiche de procédure (OEIL) · Données du Parlement européen
Consulté le:
Sources
Données : EP Open Data API
De quoi s’agit-il ?
- Adoption du règlement sur les plantes génomiques après accord.
- Mise en œuvre des nouvelles techniques génomiques dès 2026 .
- Critique de la violation du principe de subsidiarité par les États membres.
Historique des amendements (17)
Texte tel que publié par le PE, en anglais.
- Amendement 1Rejeté
Recital 34
Déposé par Christophe Clergeau · S&D
… to ensure transparency as regards the use of category 1 NGT plant
Supprimé: varieties in orderAjouté: varieties, to ensure that production chains that wish to remain free from NGT plants and NGT products can doSupprimé: so,Ajouté: so and thereby safeguard consumer trust. NGT plants that have obtained a declaration … should contain, inter alia, information on the techniques used to obtain theSupprimé: traits.Ajouté: traits as well as detection methods. For transparency reasons, the patent information and the licence declarations provided by … - Amendement 6Rejeté
Article 6 – paragraph 3 – point d a (new)
Déposé par Christophe Clergeau · S&D
Ajouté: (da) methods for sampling (including references to existing official or standardised sampling methods), detection, identification and quantification of the category 1 NGT plant. In cases where it is not feasible to provide an analytical method that identifies and quantifies, if duly justified by the person intending to undertake such a deliberate release, the modalities to comply with analytical method performance requirements shall be adapted as specified in the implementing act adopted in accordance with Article 27, point (c);
- Amendement 7Rejeté
Article 7 – paragraph 2 – point d a (new)
Déposé par Christophe Clergeau · S&D
Ajouté: (da) methods for sampling (including references to existing official or standardised sampling methods), detection, identification and quantification of the category 1 NGT plant. In cases where it is not feasible to provide an analytical method that identifies and quantifies, if duly justified by the person intending to undertake such a deliberate release, the modalities to comply with analytical method performance requirements shall be adapted as specified in the implementing act adopted in accordance with Article 27, point (c);
- Amendement 8Rejeté
Article 9 – paragraph 1 – subparagraph 2 – point d a (new)
Déposé par Christophe Clergeau · S&D
Ajouté: (da) methods for sampling, detection, identification and quantification as referred to in Article 6(3) and Article 7(2);
- Amendement 9Rejeté
Article 27 – paragraph 1 – point c
Déposé par Christophe Clergeau · S&D
… arrangements for complying with analytical method performance requirements referred to in Article Ajouté: 6(3), point (da), Article 7(2), point (da), Article 14(1), point (l), and Article 20(2).
- Amendement 19Rejeté
Recital 18 a (new)
Déposé par Anja Hazekamp, Emma Fourreau, João Oliveira +5 · The Left
Ajouté: (18a) The European Parliament has called for the Union and its Member States not to grant patents on biological material and to safeguard the freedom to operate and the breeders’ exemption for varieties. It should be ensured that breeders have full access to the genetic material of NGT plants, which by definition are not transgenic plants. Access to genetic materials can best be secured when the right of patent holders is exhausted in the hand of the breeder (breeder’s exemption). As current provisions in patent law do not provide for a full breeder’s exemption, it should be ensured that patents should not restrict the use of NGT plants by breeders and farmers. Hence, NGT plants should not be subject to patent legislation, but should for the protection of intellectual property solely be subject to the Community Plant Variety Rights (CPVR) system, as laid down in Council Regulation (EC) No 2100/94, which allows the use of the breeder’s exemption. NGT plants, their derived seeds, their plant material, associated genetic material such as genes and gene sequences, and plant traits should therefore be excluded from patentability. The exclusion from patentability should be applied in a consistent manner across legislation. Furthermore, in order to avoid patents being granted or patent applications being submitted between the date of the entry into force of this Regulation and the application of its provisions, it should be ensured that plant material is excluded from patentability from the day of entry into force of this Regulation. For patents already granted or pending patent applications covering plant material, the effects of patents should be further limited. In addition, the Commission should assess and address, in the forthcoming study, how the broader problem of patents being granted, directly or indirectly, on plant material despite previous efforts to close loopholes, should be further addressed. The assessment should address in particular the role and impact of patents on breeders' and farmers' access to plant reproductive material, seed diversity and affordable prices, as well as on innovation and in particular on opportunities for SMEs. The report of the Commission should be accompanied by the appropriate legislative proposals in order to ensure further necessary adjustments are made to the intellectual property rights framework.
- Amendement 20Rejeté
Recital 25 a (new)
Déposé par Anja Hazekamp, Emma Fourreau, João Oliveira +5 · The Left
Ajouté: (25a) Traceability requirements for food and feed produced from NGTs should be established to facilitate the accurate labelling of such products, in accordance with the requirements of Regulation (EC) No 1829/2003 of the European Parliament and of the Council of 22 September 2003 on genetically modified food and feed, so as to ensure that accurate information is available to operators and consumers to enable them to exercise their freedom of choice in an effective manner, as well as to enable control and verification of labelling claims. Requirements for food and feed produced from NGTs should be similar in order to avoid discontinuity of information in cases of change in end use.
- Amendement 23Rejeté
Article 24 a (new)
Déposé par Anja Hazekamp, Emma Fourreau, João Oliveira +5 · The Left
Ajouté: Article24a Measures to avoid the unintended presence of category 2 NGT plants Member States shall take appropriate measures to avoid the unintended presence of category 2 NGT plants in products not subject to Directive 2001/18 or Regulation 1829/2003.
- Amendement 26Rejeté
Recital 1 a (new)
Déposé par Martin Häusling · Verts/ALE
Ajouté: (1a) Allowing for new genomic techniques and their results to be patented risks giving multinational seed companies even more power over farmers’ access to seeds. In a context where large companies already have a monopoly on seeds and increasingly control natural resources, this would deprive farmers of all freedom of action by making them dependent on private companies. For this reason, patents on these products must be banned.
- Amendement 27Rejeté
Recital 15 a (new)
Déposé par Martin Häusling · Verts/ALE
Ajouté: (15a) NGT plants with the potential to persist, reproduce or spread in the environment, within or beyond fields, should be evaluated with the highest level of scrutiny in respect of the impact of such plants on nature and the environment.
- Amendement 30Rejeté
Recital 68 a (new)
Déposé par Martin Häusling · Verts/ALE
Ajouté: (68a) Effective traceability, labelling and environmental monitoring rely on the availability of reliable, accurate and validated detection methods capable of identifying and quantifying relevant substances, organisms or products. The development and use of appropriate detection methods, including those enabled by NGTs, are therefore essential to ensure transparency, consumer confidence and the effective implementation of Union law.
- Amendement 31Rejeté
Article 4 a (new)
Déposé par Martin Häusling · Verts/ALE
Ajouté: Article 4a Exclusion from patentability NGT plants, plant material, parts thereof, genetic information and the process features they contain shall not be patentable.
- Amendement 32Rejeté
Article 10 – paragraph 1
Déposé par Martin Häusling · Verts/ALE
1.
Supprimé: PlantAjouté: Category 1 NGT plants, products containing or consisting of category 1 NGT plant(s) plant reproductive material, including for breeding and scientific purposes, that contains or consists … payment or free of charge, shall bear a label with the indicationSupprimé: ‘NGT-1’,Ajouté: ‘New Genomic Techniques’. In the case of plant reproductive material, it shall be followed by the identification numbers of the NGT plants it has been … - Amendement 33Rejeté
Article 10 – paragraph 1 a (new)
Déposé par Martin Häusling · Verts/ALE
Ajouté: 1a. Appropriate document-based traceability for NGTs shall be provided by the transmission and holding of information that products contain or consist of NGT plants and product, and the unique codes for those NGTs, at each stage of their placing on the market.
- Amendement 34Rejeté
Article 11 a (new)
Déposé par Martin Häusling · Verts/ALE
Ajouté: Article11a Withdrawal of the decision If the monitoring results show that there is a risk to health or the environment, or if new scientific data supports that hypothesis, the competent authority may withdraw its decision referred to in Article 6(8) or statement referred to in Article 7(5). The withdrawal decision must be sent by registered mail to the beneficiary of the decision, who shall have 15 days in which to make observations. In that case, the marketing of the NGT plant or product shall be prohibited from the day following the date of receipt of the registered letter.
- Amendement 36Rejeté
Article 37 a (new)
Déposé par Martin Häusling · Verts/ALE
Ajouté: Article37a Amendments to Directive 98/44/EC 1. Article 4 of Directive 98/44/EC1a on the legal protection of biotechnological inventions is amended as follows: (a) In paragraph 1, the following points are added: ‘(ba) NGT plants, plant material, parts thereof, genetic information and process features they contain, as defined in Regulation (EU) .../... [O.J. please insert the number of this Regulation]; (bb) plants, plant material, parts thereof, genetic information and process features they contain that can be yielded by techniques excluded from the scope of Directive 2001/18/EC as listed in Annex I B to that directive.’ (b) the following paragraph is added: ‘3a. Paragraphs 2 and 3 shall be without prejudice to the exclusions from patentability covered in paragraph 1.’ 2. In Article 8, the following paragraph is added: ‘2a. By way of derogation from paragraphs 1 and 2, the protection conferred by a patent on a biological material possessing specific characteristics as a result of the invention shall not extend to biological material possessing the same characteristics that is obtained independently of the patented biological material and from essentially biological processes, or to biological material obtained from such material through propagation or multiplication.’ 3. In Article 9, the following paragraphs are added: ‘1a. By way of derogation from paragraph 1, a plant product containing or consisting of genetic information obtained by a patentable technical process shall not be patentable if it is not distinguishable from plant products containing or consisting of the same genetic information obtained by an essentially biological process. 1b. By way of derogation from paragraph 1, the protection conferred by a patent on a product containing or consisting of genetic information shall not extend to plant material in which the product is incorporated and in which the genetic information is contained and performs its function but which is not distinguishable from plant material obtained or which can be obtained by an essentially biological process. 1c. The protection conferred by a patent on a technical process that enables the production of a product containing or consisting of genetic information shall not extend to plant material in which the product is incorporated and in which the genetic information is contained and performs its function but which is not distinguishable from plant material obtained or which can be obtained by an essentially biological process.’ 1a Directive 98/44/EC of the European Parliament and of the Council of 6 July 1998 on the legal protection of biotechnological inventions (OJ L 213, 30.7.1998, p. 13).
- Amendement 37Rejeté
Annex II – point 2 a (new)
Déposé par Martin Häusling · Verts/ALE
Ajouté: (2a) Potential to persist, reproduce or spread in the environment, within or beyond fields
Vote par groupe politique
Comment les groupes politiques ont voté
- 10Pour
- 60Contre
- 0Abstention
- 8N'a pas voté
- 34Pour
- 6Contre
- 6Abstention
- 7N'a pas voté
- 42Pour
- 2Contre
- 0Abstention
- 1N'a pas voté
- 30Pour
- 90Contre
- 4Abstention
- 11N'a pas voté
- 20Pour
- 4Contre
- 2Abstention
- 1N'a pas voté
- 18Pour
- 59Contre
- 1Abstention
- 4N'a pas voté
- 22Pour
- 2Contre
- 3Abstention
- 2N'a pas voté
- 17Pour
- 62Contre
- 0Abstention
- 6N'a pas voté
- 8Pour
- 146Contre
- 13Abstention
- 18N'a pas voté
Les membres
Montrer 10 de 719
| Nom | Pays | Groupe | Position de vote |
|---|---|---|---|
Pour | |||
Pour | |||
Pour | |||
Pour | |||
Pour | |||
Pour | |||
Pour | |||
Pour | |||
Pour | |||
Pour |